US Patent Issued to Penland Foundation on March 18 for "Botulinum toxin for use in treatment of autism spectrum disorders" (Texas Inventor)

ALEXANDRIA, Va., March 19 -- United States Patent no. 12,251,431, issued on March 18, was assigned to Penland Foundation (Beaumont, Texas).

"Botulinum toxin for use in treatment of autism spectrum disorders" was invented by Roland M. Williams (Beaumont, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating ASD (autism) in a patient in need thereof comprises administering a botulinum toxin to the patient. The botulinum toxin may be administered by subcutaneous/intradermal injection. The subcutaneous/intradermal injection may be administered to and/or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and a sacral nerve of the patient. In infants ...